Affiliation:
1. aCenters for Disease Control and Prevention, Atlanta, Georgia
2. bEpidemic Intelligence Service, Atlanta, Georgia
Abstract
Although mpox is rare among children in the United States, pediatric cases are being reported during the 2022 multinational mpox outbreak. Vaccines and antiviral medications developed for other orthopoxviruses have recently become widely used to prevent and treat mpox in both children and adults in the United States. Although scientific literature regarding mpox in children and adolescents is scant, prior case reports can provide valuable information about the clinical features and potential complications of untreated clade II mpox in these age groups. In this review, we summarize the epidemiology and clinical features of mpox in children and adolescents and provide recommendations for clinicians regarding its diagnosis, management, and prevention. Robust, dedicated surveillance of pediatric exposures and cases in the current outbreak, including the use of vaccines and therapeutics, are needed to guide clinical management and public health strategies.
Publisher
American Academy of Pediatrics (AAP)
Subject
Pediatrics, Perinatology and Child Health
Reference72 articles.
1. World Health Organization
. 2022 monkeypox outbreak: global trends. Available at: https://worldhealthorg.shinyapps.io/mpx_global/. Accessed November 1, 2022
2. Centers for Disease Control and Prevention
. Monkeypox vaccine administration in the U.S. Available at: https://www.cdc.gov/poxvirus/monkeypox/response/2022/vaccines_ data.html. Accessed November 1, 2022
3. The changing epidemiology of human monkeypox-a potential threat? A systematic review;Bunge;PLoS Negl Trop Dis,2022
4. Maternal and fetal outcomes among pregnant women with human monkeypox infection in the Democratic Republic of Congo;Mbala;J Infect Dis,2017
5. Monkeypox disease transmission in an experimental setting: prairie dog animal model;Hutson;PLoS One,2011
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献